156 related articles for article (PubMed ID: 3942829)
21. gamma and alpha chains of human fibrinogen possess sites reactive with human platelet receptors.
Hawiger J; Timmons S; Kloczewiak M; Strong DD; Doolittle RF
Proc Natl Acad Sci U S A; 1982 Mar; 79(6):2068-71. PubMed ID: 6281794
[TBL] [Abstract][Full Text] [Related]
22. Binding of recombinant fibrinogen mutants to platelets.
Farrell DH; Thiagarajan P
J Biol Chem; 1994 Jan; 269(1):226-31. PubMed ID: 8276798
[TBL] [Abstract][Full Text] [Related]
23. Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists.
Michelson AD; Furman MI; Goldschmidt-Clermont P; Mascelli MA; Hendrix C; Coleman L; Hamlington J; Barnard MR; Kickler T; Christie DJ; Kundu S; Bray PF
Circulation; 2000 Mar; 101(9):1013-8. PubMed ID: 10704169
[TBL] [Abstract][Full Text] [Related]
24. The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets.
Gartner TK; Bennett JS
J Biol Chem; 1985 Oct; 260(22):11891-4. PubMed ID: 2995350
[TBL] [Abstract][Full Text] [Related]
25. A monoclonal antibody to the human platelet glycoprotein IIb/IIIa complex induces platelet activation.
Modderman PW; Huisman HG; van Mourik JA; von dem Borne AE
Thromb Haemost; 1988 Aug; 60(1):68-74. PubMed ID: 2973154
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the gamma chain platelet binding site on fibrinogen fragment D.
Kirschbaum NE; Mosesson MW; Amrani DL
Blood; 1992 May; 79(10):2643-8. PubMed ID: 1586714
[TBL] [Abstract][Full Text] [Related]
27. Differences between platelet and microparticle glycoprotein IIb/IIIa.
Nomura S; Suzuki M; Kido H; Yamaguchi K; Fukuroi T; Yanabu M; Soga T; Nagata H; Kokawa T; Yasunaga K
Cytometry; 1992; 13(6):621-9. PubMed ID: 1451594
[TBL] [Abstract][Full Text] [Related]
28. Regulation of platelet aggregation by post-fibrinogen binding events. Insights provided by dithiothreitol-treated platelets.
Peerschke EI
Thromb Haemost; 1995 May; 73(5):862-7. PubMed ID: 7482417
[TBL] [Abstract][Full Text] [Related]
29. Fibrin protofibril and fibrinogen binding to ADP-stimulated platelets: evidence for a common mechanism.
Hantgan RR
Biochim Biophys Acta; 1988 Jan; 968(1):24-35. PubMed ID: 2827786
[TBL] [Abstract][Full Text] [Related]
30. Synergistic action of two murine monoclonal antibodies that inhibit ADP-induced platelet aggregation without blocking fibrinogen binding.
Newman PJ; McEver RP; Doers MP; Kunicki TJ
Blood; 1987 Feb; 69(2):668-76. PubMed ID: 3026525
[TBL] [Abstract][Full Text] [Related]
31. Stabilization of platelet-fibrinogen interactions: modulation by divalent cations.
Peerschke EI
J Lab Clin Med; 1993 Jan; 121(1):135-41. PubMed ID: 8426076
[TBL] [Abstract][Full Text] [Related]
32. Biochemical and functional consequences of dissociation of the platelet membrane glycoprotein IIb-IIIa complex.
Shattil SJ; Brass LF; Bennett JS; Pandhi P
Blood; 1985 Jul; 66(1):92-8. PubMed ID: 3159447
[TBL] [Abstract][Full Text] [Related]
33. Identification of two structurally and functionally distinct sites on human platelet membrane glycoprotein IIb-IIIa using monoclonal antibodies.
McEver RP; Bennett EM; Martin MN
J Biol Chem; 1983 Apr; 258(8):5269-75. PubMed ID: 6220015
[TBL] [Abstract][Full Text] [Related]
34. Irreversible platelet fibrinogen interactions occur independently of fibrinogen alpha chain degradation and are not mediated by intact platelet membrane glycoprotein IIb-IIIa complexes.
Peerschke EI
J Lab Clin Med; 1988 Jan; 111(1):84-92. PubMed ID: 2826623
[TBL] [Abstract][Full Text] [Related]
35. Dynamics of platelet glycoprotein IIb-IIIa receptor expression and fibrinogen binding. II. Quantal activation parallels platelet capture in stir-associated microaggregation.
Frojmovic MM; Mooney RF; Wong T
Biophys J; 1994 Nov; 67(5):2069-75. PubMed ID: 7858144
[TBL] [Abstract][Full Text] [Related]
36. Studies on the binding of an alloimmune and two murine monoclonal antibodies to the platelet glycoprotein IIb-IIIa complex receptor.
Coller BS; Peerschke EI; Seligsohn U; Scudder LE; Nurden AT; Rosa JP
J Lab Clin Med; 1986 Apr; 107(4):384-92. PubMed ID: 2420911
[TBL] [Abstract][Full Text] [Related]
37. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.
Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA
Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012
[TBL] [Abstract][Full Text] [Related]
38. Aggregation of chymotrypsin-treated thrombasthenic platelets is mediated by fibrinogen binding to glycoproteins IIb and IIIa.
Niewiarowski S; Kornecki E; Hershock D; Tuszynski GP; Bennett JS; Soria C; Soria J; Dunn F; Pidard D; Kieffer N
J Lab Clin Med; 1985 Dec; 106(6):651-60. PubMed ID: 2999274
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of action of the antiplatelet peptide, arietin, from Bitis arietans venom.
Huang TF; Wang WJ; Teng CM; Ouyang C
Biochim Biophys Acta; 1991 May; 1074(1):144-50. PubMed ID: 2043664
[TBL] [Abstract][Full Text] [Related]
40. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
